Press Releases

Webcast
Q4 2017 Geron Earnings Conference Call
Mar 19, 2018 at 8:30 AM EDT
Webcast Presentation

Q4 2017 Geron Earnings Conference Call
Mar 19, 2018 at 8:30 AM EDT
Webcast
Geron at 17th Annual Needham Healthcare Conference
Mar 27, 2018 at 4:00 PM EDT
Webcast Presentation

Geron at 17th Annual Needham Healthcare Conference
Mar 27, 2018 at 4:00 PM EDT
Date Title and Summary  
Toggle Summary Geron Provides Update on Imetelstat Trials Being Conducted by Janssen
Conference Call Scheduled for 8:00 a.m. EDT Today, September 12 MENLO PARK, Calif. , Sept. 12, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today provided updates on the clinical trials being conducted by Janssen Research & Development, LLC , of the telomerase inhibitor imetelstat.
Toggle Summary Geron Announces Conference Call on September 12 at 8:00 A.M. Eastern Time
MENLO PARK, Calif. , Sept. 11, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will host a conference call on September 12, 2016 , at 8:00 a.m. Eastern Time to provide an update on the imetelstat Phase 2 trial in myelofibrosis and Phase 2/3 trial in myelodysplastic syndromes.
Toggle Summary Geron Corporation Reports Second Quarter 2016 Financial Results and Recent Events
Conference Call Scheduled for 4:30 p.m. EDT Today, August 3 MENLO PARK, Calif. , Aug. 03, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the three and six months ended June 30, 2016 and recent events. For the second quarter of 2016, the company
Toggle Summary Geron Announces Conference Call to Discuss Second Quarter 2016 Financial Results
MENLO PARK, Calif. , July 27, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the second quarter ended June 30, 2016 , on Wednesday, August 3, 2016 , after the market close. Geron’s management will also host a conference call for analysts and
Toggle Summary Geron Announces Issuance of U.S. Patents Related to Imetelstat
MENLO PARK, Calif. , July 13, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced the recent issuance of three U.S. patents related to the company’s telomerase inhibitor, imetelstat. The first patent, U.S. 9 ,375,485, has claims covering the use of telomerase inhibitor
Toggle Summary Geron Corporation Reports First Quarter 2016 Financial Results and Recent Events
Conference Call Scheduled for 4:30 p.m. EDT Today, May 5 MENLO PARK, Calif. , May 05, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the first quarter ended March 31, 2016 and recent events. First Quarter 2016 Results For the first quarter of 2016, the
Toggle Summary Geron Announces Conference Call to Discuss First Quarter 2016 Financial Results
MENLO PARK, Calif. , April 27, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the first quarter ended March 31, 2016 , on Thursday, May 5, 2016 , after the market close. Geron’s management will also host a conference call for analysts and investors
Toggle Summary Geron Announces Two Imetelstat Poster Presentations at the American Association for Cancer Research Annual Meeting
MENLO PARK, Calif. , April 20, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced two poster presentations of data from non-clinical studies of the telomerase inhibitor, imetelstat, at the 2016 American Association for Cancer Research (AACR) Annual Meeting held in New Orleans,
Toggle Summary Geron to Present at the Needham Healthcare Conference
MENLO PARK, Calif. , April 05, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett , M.D., President and Chief Executive Officer, is scheduled to present at the 15th Annual Needham Healthcare Conference in New York at 8:40 a.m.
Toggle Summary Geron Announces Presentations at American Association of Cancer Research Annual Meeting
MENLO PARK, Calif. , March 17, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that two abstracts describing non-clinical data on imetelstat have been accepted for presentation as posters at the 2016 American Association of Cancer Research (AACR) Annual Meeting to be held